These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27333958)

  • 41. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
    Finer N; James WP; Kopelman PG; Lean ME; Williams G
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):306-13. PubMed ID: 10757623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes.
    Shi YF; Pan CY; Hill J; Gao Y
    Diabet Med; 2005 Dec; 22(12):1737-43. PubMed ID: 16401321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study.
    O'Neil PM; Smith SR; Weissman NJ; Fidler MC; Sanchez M; Zhang J; Raether B; Anderson CM; Shanahan WR
    Obesity (Silver Spring); 2012 Jul; 20(7):1426-36. PubMed ID: 22421927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition, and changes in the metabolic profile of obese patients following 3-week body mass reduction program: a randomized clinical trial.
    Moszak M; Zawada A; Juchacz A; Grzymisławski M; Bogdański P
    Lipids Health Dis; 2020 Jun; 19(1):143. PubMed ID: 32563253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability of a novel herbal formulation for weight management.
    Stern JS; Peerson J; Mishra AT; Sadasiva Rao MV; Rajeswari KP
    Obesity (Silver Spring); 2013 May; 21(5):921-7. PubMed ID: 23784895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.
    Rubino D; Abrahamsson N; Davies M; Hesse D; Greenway FL; Jensen C; Lingvay I; Mosenzon O; Rosenstock J; Rubio MA; Rudofsky G; Tadayon S; Wadden TA; Dicker D;
    JAMA; 2021 Apr; 325(14):1414-1425. PubMed ID: 33755728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.
    Fidler MC; Sanchez M; Raether B; Weissman NJ; Smith SR; Shanahan WR; Anderson CM;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3067-77. PubMed ID: 21795446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of yellow pea fibre supplementation on weight loss and the gut microbiota: a randomized controlled trial.
    Lambert JE; Parnell JA; Han J; Sturzenegger T; Paul HA; Vogel HJ; Reimer RA
    BMC Gastroenterol; 2014 Apr; 14():69. PubMed ID: 24712378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
    Pi-Sunyer FX; Aronne LJ; Heshmati HM; Devin J; Rosenstock J;
    JAMA; 2006 Feb; 295(7):761-75. PubMed ID: 16478899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of lorcaserin: a combined analysis of the BLOOM and BLOSSOM trials.
    Aronne L; Shanahan W; Fain R; Glicklich A; Soliman W; Li Y; Smith S
    Postgrad Med; 2014 Oct; 126(6):7-18. PubMed ID: 25414931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial.
    Hsu CH; Tsai TH; Kao YH; Hwang KC; Tseng TY; Chou P
    Clin Nutr; 2008 Jun; 27(3):363-70. PubMed ID: 18468736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults.
    Mhurchu CN; Poppitt SD; McGill AT; Leahy FE; Bennett DA; Lin RB; Ormrod D; Ward L; Strik C; Rodgers A
    Int J Obes Relat Metab Disord; 2004 Sep; 28(9):1149-56. PubMed ID: 15311218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.
    Ishøy PL; Knop FK; Broberg BV; Bak N; Andersen UB; Jørgensen NR; Holst JJ; Glenthøj BY; Ebdrup BH
    Diabetes Obes Metab; 2017 Feb; 19(2):162-171. PubMed ID: 27717222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The metabolic effects of preferential reduction of visceral adipose tissue in abdominally obese men.
    Marks SJ; Chin S; Strauss BJ
    Int J Obes Relat Metab Disord; 1998 Sep; 22(9):893-8. PubMed ID: 9756248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of Euiiyin-tang in Korean women with obesity: A randomized, double-blind, placebo-controlled, multicenter trial.
    Cheon C; Song YK; Ko SG
    Complement Ther Med; 2020 Jun; 51():102423. PubMed ID: 32507436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The beneficial effect of soybean (Glycine max (L.) Merr.) leaf extracts in adults with prediabetes: a randomized placebo controlled trial.
    Choi MS; Ryu R; Seo YR; Jeong TS; Shin DH; Park YB; Kim SR; Jung UJ
    Food Funct; 2014 Jul; 5(7):1621-30. PubMed ID: 24873894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy and safety of Hanslim for obese patients: Study protocol for a multicenter, randomized, double-blind, multi-dose, placebo-controlled, phase IIb clinical trial.
    Lee S; Lee H; Cho Y; Kim J; Kang JW; Seo BK; Baek YH; Lee JD
    Medicine (Baltimore); 2018 Sep; 97(38):e12440. PubMed ID: 30235727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Metabolic Effects of
    Rondanelli M; Riva A; Petrangolini G; Allegrini P; Bernardinelli L; Fazia T; Peroni G; Gasparri C; Nichetti M; Faliva MA; Naso M; Perna S
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33126534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis.
    Khera R; Pandey A; Chandar AK; Murad MH; Prokop LJ; Neeland IJ; Berry JD; Camilleri M; Singh S
    Gastroenterology; 2018 Apr; 154(5):1309-1319.e7. PubMed ID: 29305933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.